Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Lidocaine for Propofol Sparing in Gastroscopy
NCT06143410Unknown
- Sponsor
- Erasmus Hospital
- Start
- Apr 2024
- Primary completion
- Aug 2024
- Modality
- Device-based Delivery, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of lidocaine in gastroscopy (2 arms), sponsored by Erasmus Hospital. Primary endpoint: Effective Dose 50 of propofol. Status: unknown.
02
Drugs
lidocaine
03
Conditions
gastroscopy
Beyond the preview
Go deeper on NCT06143410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06143410.